Katy Perry recently gave fans a glimpse into her breakfast routine while in Australia for the AFL Grand Final performance. In ...

Fueled by the rise of the blockbuster GLP-1 drugs, including Ozempic and Wegovy, thinness appears to be making a comeback in ...

$468 $279 for your first year. Make up your own mind. Build robust opinions with the FT’s trusted journalism. Offer available here until 24th October.

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...

Big Joe Henry is managing his cravings and eating healthier with Jersey Weight Loss Clinic, so he's not worried about extra ...

In a leadership shakeup, the diet company says CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

We know there are several physical risks associated with the drugs, but some are now beginning to question whether there are ...

Time-restricted eating may improve blood glucose control and help reduce fat when coupled with standard nutritional ...

Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.